KB3022
|
帕米甘草
|
101001-34-7
|
KX2-391
|
5-[4-[2-(4-嗎啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺
|
897016-82-9
|
Verubulin
|
(4-甲氧基苯基)(甲基)(2-甲基喹唑啉-4-基)胺
|
827031-83-4
|
(1R,2R)-2-fluorocyclopropanecarboxylic acid
|
(1R,2R)-2-氟環(huán)丙烷羧酸
|
127199-13-7
|
Apcin
|
Apcin
|
300815-04-7
|
PQR-530
|
PQR530
|
1927857-61-1
|
Parimifasor
|
PARIMIFASOR
|
1796641-10-5
|
RS 25344 hydrochloride
|
1-(3-硝基苯基)-3-(吡啶-4-基甲基)吡啶并[2,3-D]嘧啶-2,4(1H,3H)-二酮鹽酸鹽
|
152815-28-6
|
EG1 (Pax2 inhibitor EG1)
|
2-(4-(2-甲氧基苯甲酰氨基)苯甲酰氨基)苯甲酸
|
693241-54-2
|
MBX2329
|
1-(2-(2-乙基苯氧基)乙基)氮雜環(huán)庚烷鹽酸鹽
|
1438272-42-4
|
RBPJ Inhibitor-1(RIN1)
|
|
|
N-0437
|
5,6,7,8-四氫-6- [丙基[2-(2-噻吩基)乙基]氨基]-1-萘酚
|
92206-54-7
|
CC-885
|
CC885
|
1010100-07-8
|
(E)-(5-nitrofuran-2-yl)methylideneamino]urea
|
(E)-2-((5-硝基呋喃-2-基)亞甲基)肼甲酰胺
|
112574-44-4
|
Cadralazine
|
卡屈嗪
|
64241-34-5
|
STAT3-IN-1
|
STAT3-IN-1
|
2059952-75-7
|
CC-90009
|
CC-90009
|
1860875-51-9
|
GSK778
|
GSK778
|
2451862-42-1
|
ARP 100
|
ARP100
|
704888-90-4
|
2-(3,4-Dihydroxy-benzylidene)-benzofuran-3-one, Sphingosine Kinase Inhibitor V
|
2-(3,4-二羥基亞芐基)苯并呋喃-3(2H)-酮
|
24418-86-8
|
LMK-235
|
N-[[6-(羥基氨基)-6-氧代己基]氧基]-3,5-二甲基-苯甲酰胺
|
1418033-25-6
|
(R)-N- (4-(chlorodifluoromethoxy)phenyl)- 6-(3- hydroxypyrrolidin-1- yl)-5- (1H-pyrazol- 5-yl)nicotinamide
|
ABL-001
|
1492952-76-7
|
1-Pentanone, 1-(1,3,4,9-tetrahydro-1-phenyl-2H-pyrido[3,4-b]indol-2-yl)-
|
2,3,4,9-四氫-2-(1-氧代戊基)-1-苯基-1H-吡啶并[3,4-b]吲哚
|
334939-35-4
|
N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea
|
N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea
|
97627-24-2
|
N-(2-CHLOROETHYL)-N-ETHYL-2-BROMOBENZYLAMINE HYDROCHLORIDE
|
N-(2-CHLOROETHYL)-N-ETHYL-2-BROMOBENZYLAMINE HYDROCHLORIDE
|
40616-75-9
|
MP07-66
|
MP07-66
|
1938056-90-6
|
4-KETO ALL-TRANS-RETINOIC ACID METHYL ESTER
|
4-KETO ALL-TRANS-RETINOIC ACID METHYL ESTER
|
38030-58-9
|
4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)-
|
4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)-
|
2314467-59-7
|
STM2457
|
STM2457
|
2499663-01-1
|
2-Pyridinamine, 5,6-bis(4-methoxy-3-methylphenyl)-
|
化合物WSB1 DEGRADER 1
|
2306039-66-5
|
4-Pyrimidinamine, N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-(4-morpholinyl)-
|
化合物RIMTUZALCAP
|
2167246-24-2
|
Benzamide, N-hydroxy-4-[[[[(2-methoxyphenyl)amino]carbonyl]amino]methyl]-
|
N-羥基-4-((3-(2-甲氧基苯基)脲基)甲基)苯甲酰胺
|
1454902-97-6
|
(S)-(+)-2-METHYLBUTYL P-[(P-METHOXYBENZYLIDENE)AMINO]CINNAMATE
|
(S)-2-甲基丁基3-(4-((4-甲氧基亞芐基)氨基)苯基)丙烯酸酯
|
24140-30-5
|
BI 2536
|
BI 2536
|
755038-02-9
|
N,N'-[Sulfonylbis(1,4-phenylene)]bis(chloroacetamide)
|
N,N'-[磺?;?4,1-亞苯基)]二(2-氯乙酰胺)
|
17328-16-4
|
N-[4-(2-BROMO-4,5-DIFLUOROPHENOXY)PHENYL]-L-ASPARAGINE
|
N-[4-(2-溴-4,5-二氟苯氧基)苯基]-L-天冬酰胺
|
868359-05-1
|
TMEM16AInhibitorsRevealTMEM16A(T16Ainh-A01)
|
T16AINH-A01
|
552309-42-9
|
N'-((6-Methylpyridin-2-yl)methylene)pyrrolidine-1-carbothiohydrazide
|
N'-((6-甲基吡啶-2-基)亞甲基)吡咯烷-1-硫代肼
|
907549-72-8
|
(4-(4-methoxyphenyl)piperazin-1-yl)(2-(4-methylpiperidin-1-yl)benzo[d]thiazol-6-yl)methanone
|
(4-(4-甲氧基苯基)哌嗪-1-基)(2-(4-甲基哌啶-1-基)苯并[d]噻唑-6-基)甲酮
|
906258-69-3
|
Benzeneacetamide, N-[3-[(3,4-dihydro-2,4-dioxo-3-propylthieno[3,2-d]pyrimidin-1(2H)-yl)methyl]phenyl]-
|
N-(3-((2,4-DIOXO-3-PROPYL-3,4-DIHYDROTHIENO[3,2-D]PYRIMIDIN-1(2H)-YL)METHYL)PHENYL)-2-PHENYLACETAMID
|
2098776-03-3
|
Ethanone, 2-chloro-1-(3-indolyl)-
|
2-氯-1-(1H-吲哚-3-基)-乙酮
|
28755-03-5
|
AC710
|
N-[4-[[[[5-(叔丁基)-3-異惡唑基]氨基]羰基]氨基]苯基]-5-[(1-乙基-2,2,6,6-四甲基-4-哌啶基)氧基]-2-吡啶甲酰胺
|
1351522-04-7
|
ZL006
|
化合物ZL006
|
1181226-02-7
|
1-(5-Chloro-2-hydroxyphenyl)-ethanone 2-(2,4,6-trichlorophenyl)hydrazone
|
1-(5-Chloro-2-hydroxyphenyl)-ethanone 2-(2,4,6-trichlorophenyl)hydrazone
|
219315-22-7
|
Metronidazole-Impurity-11
|
米那普侖雜質(zhì)
|
1410831-12-7
|
CLONIDINE RELATED COMPOUND A (25 MG) (ACET-YLCLONIDINE)
|
可樂定雜質(zhì)A
|
54707-71-0
|
N2,N4-bis(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine
|
化合物 AZA1
|
1071098-42-4
|
(S)-2-Amino-N1-benzhydrylpentanediamide
|
(S)-2-氨基-N1-苯并二胺
|
2429878-52-2
|
2-methyl-5-nitroimidazol-1-ylacetic acid
|
甲硝唑雜質(zhì)G
|
1010-93-1
|
3-N-BUTYLPHTHALIDE
|
丁苯酞
|
6066-49-5
|
Oxiconazole nitrate
|
硝酸奧昔康唑
|
64211-46-7
|
MF-438
|
MF 438
|
921605-87-0
|
CDKI-73
|
CS-2259
|
1421693-22-2
|
CHR 6494 trifluoroacetate
|
CHR 6494 trifluoroacetate
|
1458630-17-5
|
ML-180
|
ML-180
|
863588-32-3
|
2-(4-fluorophenyl)-3-(isopropyl(methyl)amino)quinoxaline-6-carboxylic acid
|
BIOE-1115
|
1268863-35-9
|
CYCLIZINE HCL
|
苯甲嗪
|
82-92-8
|
Parsaclisib
|
化合物PARSACLISIB
|
1426698-88-5
|
1-(1-Methylethyl)-3-(2-phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
1-(1-Methylethyl)-3-(2-phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
1357349-91-7
|
3-(3-Bromo-2-thienyl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene fumarate
|
化合物3-(3-BROMO-2-THIENYL)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-2-ENE FUMARATE
|
216853-60-0
|
KI-7
|
KI-7
|
1489263-00-4
|
GOT1 inhibitor 2c
|
N-(4-氯苯基)-4-(1H-吲哚-4-基)哌嗪-1-甲酰胺
|
732973-87-4
|
1H-Benzotriazole-7-carboxylic acid, 1-methyl-5-(2'-methyl[1,1'-biphenyl]-4-yl)-
|
AG-636
|
1623416-31-8
|
Benzeneacetonitrile, 4-cyano-α-[[4-[[2-(dimethylamino)ethyl]methylamino]phenyl]methylene]-
|
Benzeneacetonitrile, 4-cyano-α-[[4-[[2-(dimethylamino)ethyl]methylamino]phenyl]methylene]-
|
2530161-67-0
|
5-(3-(1-naphthoyl)-1H-indol-1-yl)pentanenitrile
|
AM-2232
|
335161-19-8
|
N,N-diethyl-2-((6-methylpyridin-2-yl)methylene)hydrazinecarbothioamide
|
N,N-二乙基-2-((6-甲基吡啶-2-基)亞甲基)肼基硫酰胺
|
210700-64-4
|
1-METHYL-4-[THIOXANTHEN-9-YLIDENE]PIPERIDINE MALEATE SALT
|
馬來酸甲哌硫蒽
|
13187-06-9
|
GS143
|
4-(3-芐基-4-((5-(2-氟苯基)呋喃-2-基)亞甲基)-5-氧代-4,5-二氫-1H-吡唑-1-基)苯甲酸
|
916232-21-8
|
2,4-Thiazolidinedione, 5-[[5-[6-(4-acetyl-1-piperazinyl)-3-nitro-2-pyridinyl]-2-fluorophenyl]methylene]-
|
5-(5-(6-(4-乙?;哙?1-基)-3-硝基吡啶-2-基)-2-氟亞芐基)噻唑烷-2,4-二酮
|
853953-65-8
|
BDTX-189
|
BDTX-189
|
2414572-47-5
|
Bis(trans-cinnamic acid)anhydride
|
反式-桂皮酸酐
|
21947-71-7
|
1-(3-Nitrophenyl)-3-(4-pyridinylmethyl)-pyrido[2,3-d]pyrimidine-2,3-(1H,3H)-dionehydrochloride
|
化合物RS-25344
|
152814-89-6
|
4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine
|
AT-56
|
162640-98-4
|
MIT 9952-53
|
MIT 9952-53
|
321673-30-7
|
N-(1,2-Dimethyl-1H-benzo[d]imidazol-5-yl)-1-(3-fluorobenzyl)-1H-pyrrolo[3,2-c]pyridine-2-carboxamide
|
N-(1,2-二甲基-1H-苯并咪唑-5-基)-1-[(3-氟苯基)甲基]-1H-吡咯[3,2-c]吡啶-2-羧酰胺
|
920978-76-3
|
2-(N-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)AMINO)-2-DEOXYGLUCOSE
|
2-(N-7-硝基-2,1,3-苯并惡二唑-4-氨基)-2-脫氧-D-葡萄糖
|
186689-07-6
|
1,6-dimethyl-3-phenylpyrimido[5,4-e][1,2,4]triazine-5,7-dione
|
化合物3-PHENYLTOXOFLAVIN
|
32502-63-9
|
TH1020
|
TH1020
|
1841460-82-9
|
Benzonitrile, 3-[[(1S,2S,3R)-2,3-difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl]oxy]-5-fluoro-
|
PT2977
|
1672668-24-4
|
(4-benzylpiperazin-1-yl)(2-(4-methylpiperidin-1-yl)benzo[d]thiazol-6-yl)methanone
|
(4-芐基哌嗪-1-基)(2-(4-甲基哌啶-1-基)苯并[d]噻唑-6-基)甲酮
|
906258-48-8
|
MYF-01-37
|
MYF-01-37
|
2416417-65-5
|
TOCAINIDE
|
妥卡尼
|
41708-72-9
|
A 1120
|
A-1120
|
1152782-19-8
|
Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid)
|
利巴韋林羧基酸/利巴韋林雜質(zhì)A
|
39925-19-4
|
ALW-II-41-27
|
ALW-II-41-27
|
1186206-79-0
|
MLI-2
|
REL-3-[6-[(2R,6S)-2,6-二甲基-4-嗎啉基]-4-嘧啶基]-5-[(1-甲基環(huán)丙基)氧基]-1H-吲唑
|
1627091-47-7
|
BETd-260
|
BETd-260
|
2093388-62-4
|
MYCMI-6
|
MYCMI-6
|
681282-09-7
|
EGFR-IN-5
|
EGFR-IN-5
|
2225887-26-1
|
Tryptophan, N-indol-3-ylacetyl- (6CI)
|
N-(3-吲哚乙?;?-L-色氨酸
|
57105-53-0
|
Paquinimod
|
帕奎莫德
|
248282-01-1
|
2-Chloro-N-[(9H-fluoren-9-ylamino)carbonyl]-6-fluorobenzamide
|
2-氯-N-[(9H-芴-9-氨基)羰基]-6-氟苯甲酰胺
|
1186372-20-2
|
2-Methyl-5-(1-methylethyl)-2,5-cyclohexadiene-1,4-dione 1-[O-(2-methylbenzoyl)oxime
|
2-甲基-5-(1-甲基乙基)-2,5-環(huán)己二烯-1,4-二酮 1-[O-(2-甲基苯甲酰)肟]
|
321688-88-4
|
CHR-6494
|
3-(1H-吲唑-5-基)-N-丙基咪唑并[1,2-B]噠嗪-6-胺
|
1333377-65-3
|
N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide
|
CS-2774
|
942206-85-1
|
KM91104
|
KM 91104
|
304481-60-5
|
Butamirate Impurity 1
|
N,N-二乙基-2-苯基丁酰胺
|
92321-53-4
|
10-methyl-9-(phenoxycarbonyl) Acridinium (trifluoromethylsulfonate)
|
9-[(苯氧基)羰基]-10甲基三氟甲酰胺磺酸鹽
|
161006-14-0
|
N-OMEGA-HYDROXYL-NOR-L-ARGININE, DIHYDROCHLORIDE
|
NΩ-羥基或- L -精氨酸鹽酸鹽
|
291758-32-2
|
NS3861 >=98% (HPLC)
|
化合物NS3861
|
216853-59-7
|